James Chopas - Aug 31, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
VP/Chief Accounting Officer
Signature
/s/ David Watson, attorney-in-fact for James Chopas
Stock symbol
APLS
Transactions as of
Aug 31, 2023
Transactions value $
-$22,716
Form type
4
Date filed
9/1/2023, 04:08 PM
Previous filing
Feb 22, 2023
Next filing
Sep 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$22.7K -551 -1.79% $41.23 30.3K Aug 31, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on a Restricted Stock Unit release.